Molecular dataset: Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice

DOI

Molecular pathology reports of patients with colorectal carcinoma were collected from PALGA using specific queries from 1 October 2017 to 30 June 2019 (for details see: Figure 1A PMID: 34675090 / DOI: 10.1136/jclinpath-2021-207865). Manual curation of these reports showed 4060 patients with CRC undergoing predictive mutation analyses in this 21-month study period. Details ofthe mutation analyses (ie, technique, gene panel, diagnostic yield) were manually extracted from these reports and shown in the current dataset.

Identifier
DOI https://doi.org/10.17026/DANS-XUZ-B464
Metadata Access https://lifesciences.datastations.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.17026/DANS-XUZ-B464
Provenance
Creator E.M.P. Steeghs; GERALDINE R. Vink; MAG Elferink; QJM Voorham; H. Gelderblom; IRIS D. Nagtegaal; K. Grunberg; M.J.L. Ligtenberg
Publisher DANS Data Station Life Sciences
Contributor RU Radboud University
Publication Year 2022
Rights DANS Licence; info:eu-repo/semantics/closedAccess; https://doi.org/10.17026/fp39-0x58
OpenAccess false
Contact RU Radboud University
Representation
Resource Type Dataset
Format text/tab-separated-values; text/plain; text/csv; application/zip; application/pdf
Size 6367; 938; 742392; 18309; 421106; 441
Version 2.0
Discipline Life Sciences; Medicine